Home / Import refusals / SCS-9331616-8/51/1

FDA Import Refusal SCS-9331616-8/51/1 — Cipla, Ltd.

Cipla, Ltd. — FEI 3002806702

The FDA refused shipment SCS-9331616-8/51/1 from Cipla, Ltd. (India) on April 14, 2025. The refused product falls under Drugs and Biologics — ANALGESIC, N.E.C.. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
April 14, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
60LDB99 ANALGESIC, N.E.C.
Charges
75

Recent inspections

  • 1236690 (VAI Wed May 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1084973 (VAI Wed Mar 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073182 (NAI Fri Nov 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 997481 (VAI Fri Dec 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 882706 (NAI Fri May 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 1FX-5026714-5/20002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4357427-6/10002/4 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5554870-4/30002/1 (Thu May 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5209662-4/20002/1 (Wed May 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0349073-6/70002/1 (Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources